Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 14;13(10):2379.
doi: 10.3390/cancers13102379.

Fucoxanthin and Colorectal Cancer Prevention

Affiliations
Review

Fucoxanthin and Colorectal Cancer Prevention

Masaru Terasaki et al. Cancers (Basel). .

Abstract

Colorectal cancer (CRC), which ranks among the top 10 most prevalent cancers, can obtain a good outcome with appropriate surgery and/or chemotherapy. However, the global numbers of both new cancer cases and death from CRC are expected to increase up to 2030. Diet-induced lifestyle modification is suggested to be effective in reducing the risk of human CRC; therefore, interventional studies using diets or diet-derived compounds have been conducted to explore the prevention of CRC. Fucoxanthin (Fx), a dietary carotenoid, is predominantly contained in edible brown algae, such as Undaria pinnatifida (wakame) and Himanthalia elongata (Sea spaghetti), which are consumed particularly frequently in Asian countries but also in some Western countries. Fx is responsible for a majority of the anticancer effects exerted by the lipophilic bioactive compounds in those algae. Interventional human trials have shown that Fx and brown algae mitigate certain risk factors for CRC; however, the direct mechanisms underlying the anti-CRC properties of Fx remain elusive. Fx and its deacetylated type "fucoxanthinol" (FxOH) have been reported to exert potential anticancer effects in preclinical cancer models through the suppression of many cancer-related signal pathways and the tumor microenvironment or alteration of the gut microbiota. We herein review the most recent studies on Fx as a potential candidate drug for CRC prevention.

Keywords: cancer prevention; carotenoid; colorectal cancer; fucoxanthin; gut microbiota; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Ingestible routes of Fx in humans. (A) Chemical structures of fucoxanthin (Fx) and fucoxanthinol (FxOH). (B) Ingestible routes of Fx in humans. Whole brown algae, such as Undaria pinnatifida (Wakame) and Sargassum horneri (Akamoku), collected in the winter, when the content of Fx is the highest, may be beneficial for human health. Furthermore, Fx extracted from brown algae and microalgae can be added to various edible items to customize their route of ingestion by humans.
Figure 2
Figure 2
Possible mechanisms underlying the cancer chemopreventive effects of whole brown algae, fucoxanthin (Fx)-rich extract, Fx and fucoxanthinol (FxOH) against colorectal cancer (CRC). ACF, aberrant crypt foci; TME, tumor microenvironment. ↑, induction or increase; ↓, inhibition or decrease.

Similar articles

Cited by

References

    1. Ferlay J., Colombet M., Soerjomataram I., Mathers C., Parkin D.M., Piñeros M., Znaor A., Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer. 2019;144:1941–1953. doi: 10.1002/ijc.31937. - DOI - PubMed
    1. Arnold M., Sierra M.S., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683–691. doi: 10.1136/gutjnl-2015-310912. - DOI - PubMed
    1. American Cancer Society Colorectal Cancer Facts & Figures 2020–2022. [(accessed on 20 February 2021)]; Available online: https://www.cancer.org/research/cancer-facts-statistics/colorectal-cance....
    1. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut. 2001;48:526–535. doi: 10.1136/gut.48.4.526. - DOI - PMC - PubMed
    1. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer. 2001;91:854–862. doi: 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z. - DOI - PubMed

LinkOut - more resources